Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Amgen d.o.o.

Home Clinical Trial Sponsors and OrganizationsAmgen d.o.o.

Amgen d.o.o.

ACTIVE

Radnicka cesta 80, Zagreb, Grad Zagreb, Croatiawww.amgen.co.ukSubsidiary

Also known as:

amgen ltd

Part of Amgen, Inc.

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

22

21 active

Approvals

42

Total approvals

Agencies

1

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 1

4

18.2%

Trial Status Distribution

Active, not recruiting

21

95.5%

Recruiting

1

4.5%

Clinical Trials

Trials sponsored by this organization (22)

EU-Wide Cross-Sectional Observational Study ofLipid-Modifying Therapy Use in Secondary andPrimary Care DA VINCI

Oct 20176,000 participants

A Study to Characterize the Long-term Safety of Cinacalcet Hydrochloride in the Treatment of Secondary Hyperparathyroidism in Children With Chronic Kidney Disease On Dialysis

Active, not recruiting

Feb 201548 participants

A Multicenter, Randomized, Double-blind Study Comparing De Novo OnceMonthly and Once Every 2 Week Darbepoetin alfa Dosing for the Correction ofAnemia in Subjects With Chronic Kidney Disease Not Receiving Dialysis

Active, not recruiting

Feb 2011540 participants

Study Evaluating Once Monthly Darbepoetin Alfa Dosing for the Correction of Anemia in Non-dialysis Patients With Chronic Kidney Disease

Active, not recruiting

Dec 2010334 participants

Study Evaluating Once Monthly Darbepoetin Alfa Dosing for the Correction of Anemia in Non-dialysis Patients With Chronic Kidney Disease

Active, not recruiting

Oct 2010334 participants

A Multicenter, Randomized, Double-blind Study Comparing De Novo OnceMonthly and Once Every 2 Week Darbepoetin alfa Dosing for the Correction ofAnemia in Subjects With Chronic Kidney Disease Not Receiving Dialysis

Active, not recruiting

Feb 2010540 participants

Study Evaluating Once Monthly Darbepoetin Alfa Dosing for the Correction of Anemia in Non-dialysis Patients With Chronic Kidney Disease

Active, not recruiting

Aug 2009334 participants

A Multicenter, Randomized, Double-blind Study Comparing De Novo OnceMonthly and Once Every 2 Week Darbepoetin alfa Dosing for the Correction ofAnemia in Subjects With Chronic Kidney Disease Not Receiving Dialysis

Active, not recruiting

Aug 2009540 participants

Page 1 of 3

Approvals

Approvals by Agency

EMC

Electronic Medicines Compendium

42

Approvals

Recent Approvals

Aranesp 300 micrograms solution for injection in pre-filled pen (SureClick)

Aranesp 60 micrograms solution for injection in pre-filled pen (SureClick)

Aranesp 150 micrograms solution for injection in pre-filled pen (SureClick)

Aranesp 100 micrograms solution for injection in pre-filled pen (SureClick)

Aranesp 40 micrograms solution for injection in pre-filled pen (SureClick)

Aranesp 500 micrograms solution for injection in pre-filled pen (SureClick)

Aranesp 80 micrograms solution for injection in pre-filled pen (SureClick)

TEPEZZA 500 mg powder for concentrate for solution for infusion

Mimpara 5 mg granules in capsules for opening

News

No news articles found

On this page

Overview
Clinical Trials22
Approvals42
News

Back to Organizations